Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: ECO, PSF, CFG

Statement from the Minister of Health on Canada's Support for International Cooperation on Antimicrobial Resistance


OTTAWA, ON, Oct. 17, 2022 /CNW Telbec/ - It is estimated that more than 5,400 Canadians die every year from infections caused by bacteria that have become resistant to antibiotics. Antimicrobial resistance (AMR) costs our healthcare system $1.4B every year and is an urgent and growing threat to global health, with wide-spread socio-economic impacts.

Globally, AMR is associated with close to five million annual deaths, more than HIV/AIDS, malaria, or breast cancer. If left unaddressed, AMR could bring a return to an era where modern-day life-saving medical procedures, such as cancer treatments and joint replacements, would no longer be possible due to the risk of untreatable infection.

As AMR knows no boundaries and poses a threat to people around the world, global commitment, collaboration, and ambitious action is critical to combatting AMR. Today, I am pleased to announce we are joining international partners with a $300,000 contribution to help address AMR.

The funding supports SECURE, a newly created initiative with the mission to expand access to essential, life-saving antibiotics for countries and populations in need, and ensuring their appropriate use. SECURE's efforts will address the burden of infectious diseases and AMR in low and middle-income countries. SECURE was developed by the Global Antibiotic Research & Development Partnership (GARDP) and the World Health Organization (WHO), with support from UNICEF and the Clinton Health Access Initiative (CHAI).

Canada's contribution to SECURE's initiative will increase global AMR preparedness and support improved access to the antimicrobials upon which people around the world rely every day.

The hard-learned lessons of COVID-19 have demonstrated the importance of global readiness, collaboration, and equitable access to life-saving medicines for all. Just like COVID-19, AMR requires a united and concerted action.

In addition to our global cooperation, there are also individual level actions we can take to help address this public health threat. Next month we will recognize World Antimicrobial Awareness Week (WAAW). This year's theme is Preventing Antimicrobial Resistance Together. It's a good reminder that we can all play a part to help address AMR.

Individuals can take simple steps to reduce the spread of AMR. Keeping our vaccinations up to date, protecting ourselves from infections, speaking with a healthcare provider before using antimicrobial drugs, and using them as directed are some examples.

Lastly, it's important to recognize that, although life-saving, antibiotics are not always the answer.

The Honourable Jean-Yves Duclos, P.C., M.P.

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 02:14
Citycon Oyj's Sustainability Accounts for 2022 have been published today. Once again, Citycon was named one of Europe's Climate Leaders by Financial Times and German research company Statista. Significant and documented progress towards the company's...

at 01:55
Tetragon has released its Monthly Factsheet for February 2023. -  Net Asset Value: $2,794m-  Fully Diluted NAV Per Share: $29.96-  Share Price (TFG NA): $9.80-  Monthly NAV per share total return: -0.7%-  Monthly Return on Equity: -0.5%-  Most recent...

at 01:14
In a world of uncertainties, China's certainty is a mainstay that safeguards world peace and development, said Chinese Premier Li Qiang on Thursday, calling it "a fact that was true in the past, and even more so at present and in the future." "No...

at 01:00
THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE...

at 00:51
Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325.HK), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing. ...

at 00:43
iHuman Inc. ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022....



News published on 17 october 2022 at 15:01 and distributed by: